Straits Times Index
3,338.57 +5.77 (+0.17%) S&P 500
5,475.09 +14.61 (+0.27%) Dow
39,169.52 +50.66 (+0.13%) Nasdaq
17,879.30 +146.70 (+0.83%) Bitcoin USD
63,252.48 +1,344.68 (+2.17%) CMC Crypto 200
1,350.89 +48.82 (+3.75%)
PCRX Jul 2024 30.000 call
- Simply Wall St.
Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
With its stock down 7.9% over the past month, it is easy to disregard Pacira BioSciences (NASDAQ:PCRX). However, stock...
- GuruFocus.com
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing.
- GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference
TAMPA, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event. About Pacira Pacira BioSciences, In
